Yasser Zeid, MD
Urogynecology and Reconstructive Pelvic Surgery · Tyler, TXNPI 1548369424
Payments from drug & device makers
What this record shows
19 manufacturers reported payments, led by Momentis Surgical Inc. at 43.3% of the total. Reporting peaked in 2022 at $2,464 and has fallen 98.6% since, to $34 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in TX, where the typical reported total is $5,014.
Across 81 payments — averaging $61.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Momentis Surgical Inc.$2K
- Coloplast$1K
- Axonics, Inc.$699
- AbbVie$392
- Medtronic$214
- Myovant Sciences Inc.$152
- plus $357 from 13 others
What the payments were for
- Travel & lodging$2,89158%
- Food & beverage$2,12342%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Momentis Surgical Inc. | 8 | $2,173 |
| Coloplast | 10 | $1,027 |
| Axonics, Inc. | 9 | $699 |
| AbbVie(2 entities) | 24 | $392 |
| Medtronic(2 entities) | 6 | $214 |
| Myovant Sciences Inc. | 5 | $152 |
| Caldera Medical, Inc | 2 | $78 |
| Astellas Pharma US Inc | 2 | $40 |
| Pfizer | 2 | $31 |
| Hologic Sales And Service, LLC | 2 | $28 |
| Coopersurgical, Inc. | 1 | $26 |
| Avion Pharmaceuticals | 2 | $25 |
| Minerva Surgical, Inc | 2 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Exeltis, USA Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Organon | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Bayer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Anovo Surgical System$2,134
- ALTIS$877
- Bulkamid$516
- Axonics r-SNM System$516
- INTERSTIM$162
How this compares
$5,014 in reported general payments places this provider in the 50th percentile of 74 urogynecology and reconstructive pelvic surgery providers in Texas.
See all urogynecology and reconstructive pelvic surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 26 | $767 |
| Medroxyprogesterone Acetate | 14 | $386 |
| Oxybutynin Chloride ErOxybutynin Chloride | 15 | $205 |
| Metronidazole | 12 | $67 |
| Fluconazole | 12 | $53 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Tyler
- Russell StanleyTyler$4K
- Stephen KrausSan Antonio$372K
- Keith XavierArlington$282K
- Tomas AntoniniAustin$183K
- Amanda WhiteAustin$108K
- Gazala SiddiquiHouston$81K
- Fiona LindoHouston$66K
- Peter LotzeHouston$48K
- Tracy Cannon-SmithArlington$29K
- Teresa IrwinSan Marcos$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.